BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34814044)

  • 21. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pretreatment radiological and pathological lymph node statuses on prognosis in patients with ovarian cancer who underwent interval debulking surgery with lymphadenectomy following neoadjuvant chemotherapy.
    Komatsu H; Iida Y; Osaku D; Shimogai R; Chikumi J; Sato S; Oishi T; Harada T
    J Obstet Gynaecol Res; 2021 Jan; 47(1):152-158. PubMed ID: 32830400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic significance of systematic retroperitoneal lymphadenectomy in patients with epithelial ovarian cancer: a Meta-analysis].
    Gu HF; Zhou Y; Li YX; Ou YL; Liu JH
    Zhonghua Yi Xue Za Zhi; 2016 Oct; 96(37):3020-3025. PubMed ID: 27760666
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
    Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
    Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
    Yamazaki H; Todo Y; Shimada C; Takeshita S; Minobe S; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.
    Yokoyama Y; Sakamoto T; Sato S; Saito Y
    Eur J Gynaecol Oncol; 1999; 20(5-6):361-6. PubMed ID: 10609495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis.
    Yang C; Zhang T; Gong A; Shi C
    BMC Womens Health; 2023 Sep; 23(1):474. PubMed ID: 37667358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
    du Bois A; Reuss A; Harter P; Pujade-Lauraine E; Ray-Coquard I; Pfisterer J; ;
    J Clin Oncol; 2010 Apr; 28(10):1733-9. PubMed ID: 20194855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interval debulking surgery for advanced epithelial ovarian cancer.
    Tangjitgamol S; Manusirivithaya S; Laopaiboon M; Lumbiganon P; Bryant A
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006014. PubMed ID: 20927744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials.
    Purwar R; Ranjan R; Soni K; Pandey M; Upadhyay SK; Pai E; Kumar T
    World J Surg Oncol; 2022 Nov; 20(1):367. PubMed ID: 36419077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
    Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
    Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
    Eoh KJ; Yoon JW; Lee I; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    J Surg Oncol; 2017 Sep; 116(3):329-336. PubMed ID: 28542980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis.
    Pergialiotis V; Liatsou E; Rouvali A; Haidopoulos D; Efthymios D; Liontos M; Rodolakis A; Thomakos N
    Curr Oncol; 2022 Aug; 29(8):5763-5773. PubMed ID: 36005192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
    Chen Y; Ning Y; Zhang Q; Xie Y
    Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer.
    Matsuo K; Huang Y; Zivanovic O; Shimada M; Machida H; Grubbs BH; Roman LD; Wright JD
    Gynecol Oncol; 2019 Sep; 154(3):505-515. PubMed ID: 31279493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis.
    Zhou J; Shan G; Chen Y
    Jpn J Clin Oncol; 2016 Aug; 46(8):718-26. PubMed ID: 27272175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined pelvic and para-aortic is superior to only pelvic lymphadenectomy in intermediate and high-risk endometrial cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Papanikolaou A; Dinas K; Mavromatidis G; Guyon F; Rodolakis A; Vergote I; Kalogiannidis I
    Arch Gynecol Obstet; 2020 Jul; 302(1):249-263. PubMed ID: 32468162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.